Distal versus Ultradistal Bypass Grafts: Amputation-free Survival and Patency Rates in Patients with Critical Leg Ischaemia  by Slim, H. et al.
Eur J Vasc Endovasc Surg (2011) 42, 83e88Distal versus Ultradistal Bypass Grafts: Amputation-
free Survival and Patency Rates in Patients with
Critical Leg IschaemiaH. Slim, A. Tiwari, A. Ahmed, J.C. Ritter, H. Zayed, H. Rashid*King’s Health Partners Vascular Unit, King’s College, Guy’s and St Thomas’ Hospitals, London, UK
Submitted 13 September 2010; accepted 20 March 2011
Available online 22 April 2011KEYWORDS
Distal bypass;
Critical ischaemia;
Outcome;
AmputationTo access continuing medical
paper, please go to www.vasculareduc
* Corresponding author. H. Rashid
Surgery, King’s College Hospital, Denm
Tel.: þ44 (0) 20 3299 3339; fax: þ44
E-mail address: hisham.rashid@nh
1078-5884/$36 ª 2011 European Socie
doi:10.1016/j.ejvs.2011.03.016Abstract Objectives: Compare the outcome of distal (bypass to the crural arteries) versus
ultradistal (bypass to the pedal arteries) bypasses in patients with critical leg ischaemia (CLI).
Design: Retrospective analysis of prospectively collected data of patients with CLI undergoing
infra-popliteal bypass surgery is performed.
Materials and Methods: Patients undergoing infra-popliteal bypass at a single institution
between 2004 and 2010 are included. Patency rates at 1-year and amputation-free survival
at 12 and 48 months are analysed.
Results: Two hundred and thirty bypasses were performed in 209 consecutive patients (156
men, median age; 76 years, range; 19e96 years). One hundred and seventy nine (78%) bypass
were classified as distal and 51 (22%) as ultradistal. The incidence of diabetes mellitus was
significantly higher in the ultradistal group (pZ 0.0025). At 1-year, the distal group primary,
assisted-primary and secondary patency rates were 61.7%, 83.1% and 87.4% compared to
61.9%, 87.4% and 87.4% in the ultradistal group respectively. Amputation-free survival at 12
and 48 months was 82.9% and 61.5% in the distal group compared to 83.0% and 64.9% in the
ultradistal group.
Conclusions: This study show that both distal and ultradistal bypass have comparable outcome
regardless of the co-morbidities. The authors believe that elderly patients should be offered
ultradistal bypass if indicated to avoid major amputation.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.education questions on this
ation.com and click on ‘CME’
, Department of Vascular
ark Hill, London SE5 9RS, UK.
(0) 20 3299 4439.
s.net (H. Rashid).
ty for Vascular Surgery. PublisheIntroduction
The incidence of critical leg ischaemia (CLI) is progressively
increasing with the ageing population.1e3 Crural and pedal
arteries bypass are now firmly established as an effective
technique for the treatment of such patients. Although
there is a wide consensus that revascularisation should bed by Elsevier Ltd. All rights reserved.
84 H. Slim et al.attempted in these patients,3e5 there are still doubts
regarding the level of the bypass, with many surgeons
reluctant to perform bypasses below the ankle level.6,7
Many studies have shown good results following either
distal bypass (bypass to the crural arteries) or ultradistal
bypass (bypass to the pedal arteries). However, to our
knowledge, only one study has compared the outcome of
crural bypass versus pedal bypass at the same institution,8
though, this was undertaken in a relatively young pop-
ulation. The aim of this study is to look at the outcome of
distal versus ultradistal bypass including an elderly pop-
ulation with CLI at a single institution.Methods
All patients undergoing infrapopliteal bypass between
January 2004 and December 2010 were evaluated. This
included 230 infrapopliteal bypasses performed by two
vascular surgeons.
All patients with CLI (Rutherford classification, category
4, 5 or 6) due to long occlusive femoro-popliteal disease
and/or trifurcation disease (The Inter-Society Consensus for
Management of PAD (TASC) type C and D classification for
femoro-popliteal disease)9 requiring infrapopliteal bypass
surgery were included. Patients’ demography, details of the
operation and follow-up information were recorded and
entered prospectively into a database (Microsoft Excel,
Redmond, WA, USA) and were analysed retrospectively.
Bypass grafts were divided into two groups, namely
distal (bypass to the crural arteries) or ultradistal (bypass to
the pedal arteries). All patients underwent preoperatively
a detailed arterial duplex scan in combination with
conventional digital subtraction angiography (DSA) to
delineate the anatomy of the arterial system. Arterial pedal
arch images were taken in two planes to fully demonstrate
the state of the pedal arteries. Computed tomography and
magnetic resonance angiography were occasionally used in
selected cases. Planned angioplasty of the inflow was per-
formed prior to surgical intervention, should there be
a stenotic lesion of >50% proximal to the site of the
proposed proximal anastomosis. Any other inflow lesions
(TASC A and B) were offered preoperative angioplasty.
As a large proportion of these patients was diabetic and
had renal failure, the ankleebrachial pressure index was
not used in the assessment, due to the artificially high
readings associated with these co-morbidities. However,
duplex waveform analysis at the ankle level was carefully
studied in all patients.
The authors’ policy was to operate on patients on clin-
ical presentation and the presence of damped duplex
waveforms in the pedal arteries at the ankle level. The
decision to perform either a distal or ultradistal bypass was
based on anatomical and radiological factors to restore
straight-line flow to the foot.
The greater saphenous vein (GSV) was used as the
preferred conduit of choice. However, if unavailable, other
vein conduit or polytetrafluoroethylene (PTFE) grafts were
used. Preoperative duplex of the superficial vein for
mapping of both GSVs was performed in all patients,
according to a standard protocol. The lesser saphenous
veins (LSVs) and arm veins (bilateral cephalic and basilic)were mapped using a similar technique, if needed. The
smallest vein conduit used was 2 mm in internal diameter.
This has been shown to have good patency rate in infrain-
guinal and infrapopliteal bypasses.10
The tunnelling of the bypass graft was performed
anatomically. Bypasses to the anterior tibial and dorsalis
pedis arteries were tunnelled laterally through the inter-
osseousmembrane, whereas bypasses to the peroneal artery
were performed via a medial approach. Intra-operative
continuous-wave Doppler was used to assess the graft
patency at the end of the procedure for quality control.
Postoperative anticoagulation was maintained using subcu-
taneous therapeutic dose of low-molecular-weight heparin
(Clexane, Sanofi Winthrop Industrie, France) adjusted
according to patients’ body weight (1.5 mg kg1 once daily)
in all bypasses and maintained throughout the in-hospital
period. Anti-platelet and statin therapy was initiated
before surgery, and maintained postoperatively.
All patients were recruited into a 1-year duplex graft
surveillance programme. Graft follow-up scans were per-
formed prior to hospital discharge and then every 3 months
for the first year. A threatened graft was diagnosed upon
the finding of focal peak systolic flow velocity
>200 cm s1, velocity ratio exceeding 2.0 (50% stenosis) or
global graft flow velocity uniformly <45 cm s1. Patients
with threatened grafts were offered urgent angiography,
and if a significant stenosis was confirmed, immediate
angioplasty was performed. If this was unsuccessful or if
the stenosis recurred, then corrective surgery was under-
taken. Patients were discharged from the surveillance
programme, only if they completed a full intervention-free
year of surveillance.
The distal bypass group was analysed separately from
the ultradistal group. The primary end points were
amputation-free survival and primary, assisted primary and
secondary patency rates of the bypass leg. Only data from
the first year of follow-up was analysed. KaplaneMeier life-
table analysis, log-rank and chi-square tests were used
where appropriate. P values <0.05 were considered
significant. Statistical analysis was performed using the
Prism software 5.0 (GraphPad Software, La Jolla, CA, USA).Results
A total of 209 patients with CLI underwent 230 infrapopliteal
bypasses. Out of the 230 bypasses, 179 (78%) were classified
as distal and 51 (22%) as ultradistal. The demographic
characteristics and risk factors (defined and graded
according to the Society of Vascular Surgeons/International
Society for Cardiovascular Surgery (SVS/ISCVS) recom-
mended criteria)2 for both groups are summarised in Table
1. Diabetes mellitus was significantly higher in the ultra-
distal group (pZ 0.0025). In the distal bypass group, 46
(28.0%) patients had renal insufficiency, out of which 37 had
impaired renal function (creatinine range; 123e416 mmol,
median; 171 mmol), seven on haemodialysis, one on perito-
neal dialysis and one with kidney transplant. In the ultra-
distal bypass group, 15 (33.3%) patients had renal
insufficiency, out of which, nine had impaired renal function
(creatinine range; 150e263 mmol, median 177 mmol) and six
on haemodialysis.
Table 1 Patients’ demography in both groups.
Distal bypass group (nZ 164) Ultradistal bypass group (nZ 45) P value
Median age (range) 76 years (19e96) 73 years (46e90)
Men 117 (71%) 39 (87%) 0.0517
Diabetes mellitus 99 (60.4%) 38 (84.4%) 0.0025
Renal insufficiency 46 (28.0%) 15 (33.3%) 0.5789
Hypertension 132 (80.5%) 39 (86.7%) 0.3914
Ischaemic heart disease 73 (44.5%) 19 (42.2%) 0.8659
Smokers/Ex smokers 101 (61.1%) 31 (68.9%) 0.3897
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presenting symptom was ischaemic ulcers in 114 (49.6%)
cases, gangrene in 62 (27.0%) and rest pain in 54 (23.5%).
Autologous GSV was used in 201/230 (87.4%) cases, arm
veins in six (2.6%) and PTFE with venous cuff in 23 (10.0%).
Twenty-five out of the 230 cases had previous open
vascular procedures. Eleven were on the ipsilateral leg (one
iliofemoral bypass, eight femoro-popliteal bypasses, seven
femoro-distal bypasses and seven endarterectomies) and 14
on the contralateral leg (six femoro-popliteal bypasses, five
femoro-distal bypasses and three endarterectomies).
Seventy out of the 230 legs were found to have inflow
disease >50% stenosis and underwent successful preoper-
ative inflow angioplasty. Target arteries were six common
iliac, three external iliac, two common femoral, 27 super-
ficial femoral (SFA), 19 popliteal artery (PA) and 13
combined SFA and PA.
Details of the inflow artery in both groups are summar-
ised in Table 2. The site of the distal anastomosis in the
distal bypass group was tibioperoneal trunk 24 (13.4%),
anterior tibial in 67 (37.4%), peroneal in 40 (22.3%) and
posterior tibial artery in 48 (26.8%) cases. The site of the
distal anastamosis in the ultradistal group was infra-
malleolar posterior tibial artery in 12 (23.5%), dorsalis pedis
in 30 (58.8%) and the medial plantar in nine (17.6%) cases.
The overall 30-day mortality rate was 1.7% (4/230). In
the distal group, the 30-day mortality rate was 2.2% (4/
179), compared with none in the ultradistal group. The
overall 1-year mortality rate was 12.2% (28/230). In the
distal group, the 1-year mortality rate was 12.3% (22/179),
compared with 11.8% (6/51) in the ultradistal group
(pZ 0.578).Table 2 Site of proximal anastomosis in both groups.
Inflow artery Distal bypass
group (nZ 179)
Ultradistal
bypass group
(nZ 51)
External iliac 2 (1.1%) 0
Common femoral 38 (21.1%) 3 (5.9%)
Deep femoral 1 (0.6%) 0
Superficial femoral 63 (35.0%) 4 (7.8%)
Above knee popliteal 18 (10.0%) 2 (3.9%)
Below knee popliteal 55 (30.7%) 42 (82.4%)
Posterior tibial 2 (1.1%) 0The percentage of threatened grafts that required
salvage angioplasty was similar in the distal and ultradistal
groups (64/179 (36%) and 17/51 (33%) respectively,
pZ 0.8683). The number of repeated salvage angioplasties
was 81/179 (45%) in the distal group compared with 21/51
(41%) in the ultradistal group. This was not statistically
different (pZ 0.6349). Details of the salvage angioplasty
sites are summarised in Table 3. Nine of the 81 and three of
21 salvage angioplasties in the distal and ultradistal groups,
respectively, were for the previously treated inflow artery.
A total of 182 bypasses had at least 1-year follow-up.
Out of these bypasses; 143 grafts were in the distal group
and 39 grafts in the ultra-distal group. At 1 year, the distal
group’s primary, assisted primary and secondary patency
rates were 61.7%, 83.1% and 87.4%, respectively. This
compares with patency rates of 61.9%, 87.4% and 87.4% in
the ultradistal group (Figs. 1e3). The amputation-free
survival at 12 and 48 months was similar in both groups
(82.9% and 61.5% in the distal group compared with 83.0%
and 64.9% in the ultradistal group) (Fig. 4). There was no
statistically significant difference between the groups.
During the total follow-up period, 15 legs required major
amputations in the distal group and two in the ultradistal
group. The limb salvage rate during this period was 92% and
96% in the distal and ultradistal groups, respectively. Sixty
legs required minor amputation and 107 required ulcer
debridement. All ulcers andminor amputations healed fully;
however, in 14 cases with extensive foot debridement (area
measuring> 7 cm) split-thickness skin graft was required.
At 1 year, in the distal group, 20 grafts occluded and
seven legs required major amputations. Out of the 20
occluded grafts, 10 occluded between 65 and 232 days
following the procedure. However, by the time of graft
occlusion, the tissue loss had healed and this did not result
in major amputation. In the ultradistal group, six grafts
occluded and one patient required major amputation. Out
of the six grafts, four occluded between 92 and 204 days
following the bypass with healed ulcers.Table 3 Site of salvage angioplasty in both groups.
Distal bypass
group (nZ 81)
Ultradistal bypass
group (nZ 21)
Inflow 18 (22.2%) 4 (19.0%)
Graft 50 (61.7%) 16 (76.2%)
Outflow 13 (16.0%) 1 (4.8%)
Figure 1 KaplaneMeier analysis of the primary patency rate
of distal and ultradistal bypasses.
Figure 3 KaplaneMeier analysis of the secondary patency
rate of distal and ultradistal bypasses.
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With an increasingly aged population, life-limiting CLI is
becoming a more frequent presentation of peripheral
arterial disease (PAD). CLI prevalence is estimated at 1% of
the population aged 60 years or older, with the percentage
increasing with age.2,3 These elderly patients often suffer
from severe co-morbidities, such as ischaemic heart disease
and renal dysfunction.11,12 However, recent guidelines from
the Second European Consensus Document on chronic limb
ischaemia,2 the Transatlantic Intersociety Consensus
Document on Revascularisation (TASC)3 and the interna-
tional consensus on the management of the diabetic foot5
suggested that revascularisation is the optimal manage-
ment in these patients before considering major
amputation.
Treatment options for patients with CLI vary based on
the type and level of the occlusive lesion, patient factors
and the availability of expertise. Long-term results of
minimally invasive endovascular treatments for distal
arterial revascularisation need to be considered with
caution.13 Even 1-year patency rates for subintimal angio-
plasty are still not comparable to surgery (50% vs. >80%).14
Results from the multicentre BASIL (Bypass versusFigure 2 KaplaneMeier analysis of the assisted primary
patency of distal and ultradistal bypasses.Angioplasty in Severe Ischaemia of the Leg) trial have
suggested no difference in outcomes with the use of either
subintimal or transluminal angioplasty.15 It also showed
that >90% of the failed angioplasties required a further
surgical intervention resulting in worse amputation-free
and overall survival compared with those who had
surgery performed in the first instance.15 Due to these
limitations in the available treatment options and a rela-
tively elderly patient group, infrapopliteal arterial recon-
struction has remained a challenging yet hopeful
treatment option for CLI.
Autogenous vein bypass to crural and pedal arteries is
now firmly established as an effective technique for the
treatment of CLI. Recent series of crural artery revascu-
larisation showed at 5-year a secondary patency rate of
68e83%, limb salvage rate of 81e93% and patient survival
rate of 45e47%.16e18 Other series for pedal artery revas-
cularisation showed at 5 years a secondary patency rate of
63e77%, limb salvage rate of 74e87% and patient survival
rate of 49e50%.19e21 However, there are little data
comparing the outcome between both distal and ultradistal
bypass at the same institution. Schneider et al.8 demon-
strated a 3-year primary graft patency of 58% for pedal
versus 61% for tibial bypass, secondary patency of 82% for
pedal versus 79% for tibial bypasses, limb salvage of 92% forFigure 4 12 and 48 months amputation-free-survival analysis
of distal and ultradistal bypasses.
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pedal versus 64% for tibial bypasses. However, according to
the authors, these were “properly selected patients” and
the mean age for the study population was 66 years for
pedal bypass and 69 years for tibial bypass. The operative
30-day mortality rates were higher for pedal compared with
tibial bypasses (9% vs. 2%, pZ 0.021). In the current series,
there was no significant difference in the 30-day mortality
between the two groups (pZ 0.578). In the current series,
the authors report an older group of patients with a median
age of 77 years (range; 19e96 years) for the distal group
and 74 years (range; 45e90 years) for the ultradistal group.
The distal anastomosis site was decided on taking into
consideration the patency of the crural and pedal arteries
and the site of the foot-tissue loss requiring revascularisa-
tion, respecting the foot angiosome principle to get the
best results.22 However, in the majority of patients, only
one run-off artery to the foot was present.
The primary, assisted primary and secondary patency
rates between both groups were comparable at 1 year. The
relatively low primary patency rates in the current series
can be explained by the structured and meticulous duplex
surveillance programme picking up early graft abnormality
(50% stenosis) requiring radiological or surgical interven-
tion. A clearly defined follow-up system with a duplex
surveillance programme has proven to be beneficial for
patency related outcome.23
In the current series, the distal bypass group had
a higher number of threatened grafts identified during the
surveillance programme (40.6% compared with 26.9% in the
ultradistal group); however, the need for secondary inter-
vention was not statistically significant between the two
groups (pZ 0.6349).
Similarly, the amputation-free survival rates at 48
months in both groups suggest that, despite an increased
age and additional co-morbidities, most of the patients had
a good outcome after arterial reconstruction (61.5% in the
distal group compared with 64.9% in the ultradistal group).
In this study, the majority of patients in the ultradistal
group were diabetic (84.4%), with typical anatomical
pattern of atherosclerosis seen in diabetes mellitus
patients sparing the superficial femoral, popliteal and
pedal arteries. This allowed the majority of the proximal
anastomoses to be taken from the PA (82.4% below the knee
and 3.9% above the knee popliteal). The advantages of such
distally based inflow lead to shorter grafts with short
segments of conduit, making surgery feasible in patients
with limited autologous vein availability, a feature quite
common in this patient group due to previous cardiac or
vascular procedures. Further, short-length bypasses are
presumed to have better haemodynamics compared with
longer grafts as stated by Asher et al.24 In addition, larger
incision and groin dissections are avoided and grafts are not
subjected to knee-joint movements, if taken from below-
knee PA.25 Due to these particular important points, the
authors managed to perform all ultradistal bypasses using
venous conduits (38 with GSV and one with arm vein).
Ultradistal bypass using GSV has proven to have the best
durability results. As shown in the series by Pompeselli
et al. (1032 pedal artery bypasses), the 5-year patency of
bypasses with the GSV was 65%, whereas with other graft
material was only 38%.20In this series, the ultradistal group had fewer grafts
requiring salvage angioplasty of the runoff artery compared
with the distal group. However, due to the small sample
size, this did not achieve statistical significance. The
authors believe that positioning the graft in the ultradistal
region avoids the progression of disease occurring in the
crural vessels that is more frequently seen in distal bypass.
The authors acknowledge that a propensity score would
have been ideal to have a conclusive analysis between the
two groups; however, the sample size could not allow this
analysis.
Conclusion
This study shows that both distal and ultradistal bypass
have comparable outcome, regardless of the co-
morbidities. The authors believe that elderly patients
should be offered ultradistal bypass, if indicated to avoid
major amputation.
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